Literature DB >> 21486865

Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Tienan Zhu1, Qiulan Ding, Xia Bai, Xiaoyan Wang, Florentia Kaguelidou, Corinne Alberti, Xuqian Wei, Baolai Hua, Renchi Yang, Xuefeng Wang, Zhaoyue Wang, Changgeng Ruan, Nicole Schlegel, Yongqiang Zhao.   

Abstract

BACKGROUND: Inherited deficiency of antithrombin, protein C and protein S, three important, naturally occurring coagulation inhibitors, might play a major role in the occurrence of venous thromboembolism in Chinese. The establishment of age- and gender-related normal ranges of these inhibitors is crucial for an accurate diagnosis of these deficiencies. DESIGN AND METHODS: We designed a prospective cross-sectional study recruiting healthy adults from four university-affiliated hospitals in China. Antithrombin, protein C and protein S were studied by measuring their activity. Gene analysis was performed when natural anticoagulant deficiency was suspected. Polymorphisms of the factor V gene were searched for among subjects who were positive for activated protein C resistance.
RESULTS: In 3493 healthy Chinese adults (1734 men, 1759 women; age 17-83 years), we found higher age-adjusted activities for protein C and protein S in men than in women but no sex difference for antithrombin. In women, mean protein C and protein S activities increased with age. In men, mean protein C levels increased with age up to the age of 49 but decreased after 50 years old; mean protein S levels decreased after 50 years of age. Antithrombin levels remained stable over time in women but decreased significantly after 50 years of age in men. Reference values according to age and sex allowed the identification of 15 genetic variants (protein C:10, antithrombin:3, protein S:2) in subjects with protein activity below the 1(st) percentile.
CONCLUSIONS: This is the largest survey ever conducted in the healthy general Chinese population. These normal ranges provide the essential basis for the diagnosis and treatment of thrombosis in Chinese.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21486865      PMCID: PMC3128223          DOI: 10.3324/haematol.2010.037515

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

1.  An extremely low prevalence of factor V Leiden, FIIG20210A and FXIIIV34L in Taiwan Chinese population.

Authors:  Hong Zheng; Ching-Cherng Tzeng; Christopher Butt; Edward Randell; Ya-Gang Xie
Journal:  Thromb Haemost       Date:  2002-06       Impact factor: 5.249

2.  Prevalence of protein S deficiency in the Japanese general population: the Suita Study.

Authors:  T Sakata; A Okamoto; T Mannami; H Tomoike; T Miyata
Journal:  J Thromb Haemost       Date:  2004-06       Impact factor: 5.824

3.  Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese.

Authors:  T Sakata; A Okamoto; T Mannami; H Matsuo; T Miyata
Journal:  J Thromb Haemost       Date:  2004-03       Impact factor: 5.824

4.  Frequency of natural coagulation inhibitor (antithrombin III, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis.

Authors:  E Suehisa; T Nomura; T Kawasaki; Y Kanakura
Journal:  Blood Coagul Fibrinolysis       Date:  2001-03       Impact factor: 1.276

5.  No association between thrombosis and factor V gene polymorphisms in Chinese Han population.

Authors:  Hu Yanqing; Chen Fangping; Xie Qinzhi; Jian Zaifu; Wang Guangping; Zuo Xiaoxia; Pu Xiaoqun
Journal:  Thromb Haemost       Date:  2003-03       Impact factor: 5.249

Review 6.  A review of the technical, diagnostic, and epidemiologic considerations for protein S assays.

Authors:  Andrew J Goodwin; Frits R Rosendaal; Kandice Kottke-Marchant; Edwin G Bovill
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

7.  Absence of thrombosis in subjects with heterozygous protein C deficiency.

Authors:  J Miletich; L Sherman; G Broze
Journal:  N Engl J Med       Date:  1987-10-15       Impact factor: 91.245

8.  A comparison of polymorphism in the 3'-untranslated region of the prothrombin gene between Chinese and Caucasians in Australia.

Authors:  D K Chan; G Hu; H Tao; D Owens; C M Vun; J Woo; B H Chong
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

9.  Deep vein thrombosis is not rare in Asia--the Singapore General Hospital experience.

Authors:  L H Lee; K Q Gu; D Heng
Journal:  Ann Acad Med Singapore       Date:  2002-11       Impact factor: 2.473

10.  Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census.

Authors:  Paul D Stein; Fadi Kayali; Ronald E Olson; Creagh E Milford
Journal:  Am J Med       Date:  2004-04-01       Impact factor: 4.965

View more
  16 in total

Review 1.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

2.  Protein S deficiency in patients from the French Basque Country with various thrombotic conditions: a rarer inherited trait in autochthonous individuals?

Authors:  Frédéric Bauduer
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

Review 3.  Progress in research into the genes associated with venous thromboembolism.

Authors:  Lian-Xing Zhao; Bo Liu; Chun-Sheng Li
Journal:  World J Emerg Med       Date:  2015

4.  Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2015-06-10       Impact factor: 3.162

5.  Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays.

Authors:  Qiulan Ding; Likui Yang; Peyman Dinarvand; Xuefeng Wang; Alireza R Rezaie
Journal:  Blood       Date:  2015-02-04       Impact factor: 22.113

6.  Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.

Authors:  Qiulan Ding; Likui Yang; Seyed Mahdi Hassanian; A R Rezaie
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

Review 7.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

8.  Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with thromboembolism and in the general population.

Authors:  Hee-Jin Kim; Ja-Young Seo; Ki-O Lee; Sung-Hwan Bang; Seung-Tae Lee; Chang-Seok Ki; Jong-Won Kim; Chul Won Jung; Duk-Kyung Kim; Sun-Hee Kim
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

9.  Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.

Authors:  Liang Tang; Tao Guo; Rui Yang; Heng Mei; Huafang Wang; Xuan Lu; Jianming Yu; Qingyun Wang; Yu Hu
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

10.  Bidirectional risk between venous thromboembolism and cancer in East Asian patients: synthesis of evidence from recent population-based epidemiological studies.

Authors:  Victor C Kok
Journal:  Cancer Manag Res       Date:  2017-12-05       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.